Silver polymethyl methacrylate antibacterial bone cement

Area of Science:

• Biomaterials Science
• Inorganic Chemistry
• Microbiology

Background:

• Conventional bone cements often incorporate organic antibiotics, which can lead to antibiotic resistance.
• There is a need for alternative antibacterial agents with broad-spectrum activity and low potential for resistance.
• Silver compounds offer inherent antimicrobial properties and have a low risk of inducing allergic reactions.

Purpose of the Study:

• To develop an improved antibacterial bone cement by incorporating inorganic silver compounds into polymethyl methacrylate (PMMA).
• To evaluate the in vitro antibacterial efficacy and in vivo biocompatibility of silver-PMMA composites.
• To assess the impact of silver compound addition on the mechanical properties of PMMA bone cement.

Main Methods:

• Inorganic silver compounds (AgCl, Ag-AgCl, Ag2O, Ag2SO4, Ag3PO4) were added to PMMA at concentrations of 0.05% to 1% by weight.
• In vitro antibacterial activity was tested against bacterial cultures.
• Compressive strength was measured to assess mechanical properties.
• In vivo biocompatibility was evaluated through rabbit muscle implantation for up to 12 weeks.

Main Results:

• All tested silver-PMMA composites exhibited antibacterial activity.
• Silver sulfate (Ag2SO4)-PMMA showed particularly strong and sustained antibacterial efficacy, even after 7 weeks of incubation.
• Compressive strength was unaffected, except for Ag2O which showed a slight decrease.
• Biocompatibility tests revealed minimal tissue reactivity, comparable to plain PMMA.

Conclusions:

• Silver-PMMA composites are effective antibacterial bone cements with broad-spectrum activity.
• Silver sulfate-PMMA demonstrates superior and long-lasting antibacterial properties.
• The developed silver-PMMA exhibits excellent biocompatibility and maintains mechanical integrity, presenting a viable alternative to antibiotic-loaded bone cements.